Effects of Traditional Herbal drugs along with hormone therapy in Stage IV Prostatic cancer patients

Accessing the therapeutic benefit of traditional herbal adjuncts combined with hormone therapy in Stage IV Prostatic carcinoma - Nil

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/06/112920

Enrollment

Registered

2026-06-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C61- Malignant neoplasm of prostate

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1. diagnosed cases of Stage IV prostatic carcinoma (Adenocarcinoma) 2. patients with Gleasons Scale 7 and above 3. patients, who are ready to sign the informed consent, follow the protocol and willing to participate in clinical study voluntarily

Exclusion criteria

Exclusion criteria: 1. First three stages of prostatic carcinoma 2. patients who do not fit into the Gleasons scale 3. patients who fail to give written consent

Design outcomes

Primary

Measure	Time frame
1. CRP 2. Pap 3. 4k score testTimepoint: Day 0, Day 30, Day 60 and Day 90	—

Secondary

Measure	Time frame
1. Serum PSA 2. Pet ScanTimepoint: Day 0 and Day 90	—

Countries

India

Contacts

Public ContactARSHEED IQBAL

Reginoal Research Institute of Unani Medicine

drarsheediqbal@gmail.com07006019911

Outcome results